Compare · CTSH vs IQV
CTSH vs IQV
Side-by-side comparison of Cognizant Technology Solutions Corporation (CTSH) and IQVIA Holdings Inc. (IQV): market cap, price performance, sector, and recent activity on the wire.
Summary
- CTSH operates in Technology, while IQV operates in Health Care - the two are in different parts of the market.
- IQV is the larger of the two at $28.00B, about 1.4x CTSH ($20.71B).
- Over the past year, CTSH is down 42.1% and IQV is up 8.5% - IQV leads by 50.6 points.
- CTSH has been more active in the news (60 items in the past 4 weeks vs 8 for IQV).
- Both have 25 recent analyst ratings on file.
- Company
- Cognizant Technology Solutions Corporation
- IQVIA Holdings Inc.
- Price
- $43.67-10.53%
- $167.84-1.66%
- Market cap
- $20.71B
- $28.00B
- 1M return
- -14.15%
- -3.13%
- 1Y return
- -42.11%
- +8.46%
- Industry
- EDP Services
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ
- NYSE
- IPO
- 1998
- 2013
- News (4w)
- 60
- 8
- Recent ratings
- 25
- 25
Cognizant Technology Solutions Corporation
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. The company operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. It offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; and enhanced compliance, integrated health management, claims investigative services, and patient experience, as well as services that drive operational improvements in areas, such as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. The company also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and cloud, interactive, and IoT services to information, media and entertainment, and communications and technology companies. Cognizant Technology Solutions Corporation was founded in 1994 and is headquartered in Teaneck, New Jersey.
IQVIA Holdings Inc.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Latest CTSH
- Cognizant expands cross-platform agentic AI with new ServiceNow AI Agent interoperability
- Entry-Level Work Remains Essential: 94% of HR Leaders Expect AI to Create New Entry-Level Roles, Cognizant and Pearson Study Reveals
- SVP, Controller & CAO Kerdman Alina converted options into 199 shares, covered exercise/tax liability with 65 shares and sold $6,876 worth of shares (133 units at $51.70) as part of a pre-agreed trading plan, increasing direct ownership by 0.10% to 990 units (SEC Form 4)
- Chief Financial Officer Dalal Jatin P converted options into 2,494 shares and covered exercise/tax liability with 1,346 shares, increasing direct ownership by 2% to 58,111 units (SEC Form 4)
- Chief People Officer Diaz Kathryn covered exercise/tax liability with 372 shares and converted options into 747 shares, increasing direct ownership by 2% to 22,643 units (SEC Form 4)
- Chief Executive Officer Singisetti Ravi Kumar converted options into 5,987 shares and covered exercise/tax liability with 3,230 shares, increasing direct ownership by 2% to 122,658 units (SEC Form 4)
- CLO, CAO & Corporate Secretary Kim John Sunshin covered exercise/tax liability with 888 shares and converted options into 1,646 shares, increasing direct ownership by 2% to 42,892 units (SEC Form 4)
- President - Americas Gummadi Surya converted options into 1,995 shares and covered exercise/tax liability with 987 shares, increasing direct ownership by 3% to 37,200 units (SEC Form 4)
- President Operations CMD India Varrier Rajesh converted options into 1,271 shares and covered exercise/tax liability with 466 shares, increasing direct ownership by 9% to 10,128 units (SEC Form 4)
- President - APJ and ISG Ayyar Balu Ganesh converted options into 848 shares, increasing direct ownership by 0.76% to 112,172 units (SEC Form 4)
Latest IQV
- IQVIA downgraded by Morgan Stanley with a new price target
- Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chain
- IQVIA Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
- SEC Form 8-K filed by IQVIA Holdings Inc.
- IQVIA Announces Pricing of Senior Notes
- SEC Form 8-K filed by IQVIA Holdings Inc.
- IQVIA Announces Offering of Senior Notes
- IQVIA CEO to Speak at Jefferies Global Healthcare Conference
- IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities
- SEC Form 4 filed by Director Wims Morris Leslie